Shasun Pharmaceuticals Ltd.[Merged] - Research Center
524552 SHASUNPHAR Group (B) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 15 | Jun' 15 | Mar' 15 | Dec' 14 | Sep' 14 | |
|---|---|---|---|---|---|
| Sales | 268.43 | 257.58 | 275.12 | 273.29 | 279.60 |
| Operating profit | 30.83 | 27.21 | 25.03 | 40.27 | 27.59 |
| Interest | 10.22 | 10.22 | 11.83 | 13.08 | 10.81 |
| Gross profit | 24.73 | 18.78 | 20.02 | 28.42 | 21.20 |
| EPS (Rs) | 1.74 | 1.04 | 1.15 | 3.18 | 1.94 |
Quarterly
results in details
| Sep' 15 | Jun' 15 | Mar' 15 | Dec' 14 | Sep' 14 | |
|---|---|---|---|---|---|
| Other income | 4.12 | 1.79 | 6.82 | 1.23 | 4.42 |
| Stock adjustment | -10.19 | -0.86 | -1.88 | -16.28 | 3.75 |
| Raw material | 155.51 | 149.06 | 160.99 | 164.36 | 158.92 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 32.56 | 26.53 | 30.68 | 27.78 | 30.07 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 59.72 | 55.64 | 60.30 | 57.16 | 59.27 |
| Provisions made | - | - | - | - | - |
| Depreciation | 11.62 | 11.06 | 10.10 | 9.32 | 9.52 |
| Taxation | 1.38 | 0.73 | 4.48 | - | - |
| Net profit / loss | 11.73 | 6.99 | 6.90 | 19.10 | 11.68 |
| Extra ordinary item | - | - | 1.46 | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 13.45 | 13.45 | 12.03 | 12.03 | 12.03 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | 434.81 | 434.81 | 363.81 | 363.81 | 363.81 |
| Agg.of non promotoholding (%) | 64.68 | 64.68 | 60.51 | 60.51 | 60.51 |
| OPM (%) | 11.49 | 10.56 | 9.10 | 14.74 | 9.87 |
| GPM (%) | 9.07 | 7.24 | 7.10 | 10.35 | 7.46 |
| NPM (%) | 4.30 | 2.69 | 2.45 | 6.96 | 4.11 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis